Tolerability and efficacy of paliperidone ER compared to olanzapine in the treatment of schizophrenia: A randomized, double–blind, multicentric trial

BACKGROUND: Paliperidone is an active metabolite of risperidone and actss through a combination of central dopamine Type 2 (D2) and serotonin Type 2 (5HT2A) receptor antagonism. AIM: The present randomized, double-blind, multicentric trial was designed to determine the safety and efficacy of paliper...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Sandip, Joshi, Dipti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425242/
https://www.ncbi.nlm.nih.gov/pubmed/22969177
http://dx.doi.org/10.4103/0972-6748.98411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425242/
https://www.ncbi.nlm.nih.gov/pubmed/22969177
http://dx.doi.org/10.4103/0972-6748.98411

Ejemplares similares